Corcept Therapeutics
CORT
#2481
Rank
$7.45 B
Marketcap
$69.49
Share price
1.62%
Change (1 day)
-3.06%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): $7.24 Million USD

According to Corcept Therapeutics 's latest financial reports the company's current earnings are $0.76 Billion USD. In 2025 the company made an earning of $66.46 Million USD a decrease over its 2024 earnings that were of $0.16 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $7.24 M-89.1%
2025 $66.46 M-58.84%
2024 $0.16 B29.65%
2023 $0.12 B7.2%
2022 $0.11 B-7.05%
2021 $0.12 B-5.01%
2020 $0.13 B12.79%
2019 $0.11 B26.61%
2018 $92.15 M74.51%
2017 $52.8 M548.72%
2016 $8.14 M-227.03%
2015 -$6.41 Million-79.58%
2014 -$31.39 Million-31.79%
2013 -$46.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$15.78 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$10.59 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.12 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$13.15 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.59 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$1.4 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$27.45 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA